Phospho-S6 (pS6), a marker for the mTOR signaling pathway, is upregulated in HPV-associated cancers and has been extensively used as a biomarker for characterizing progressive neoplastic disease in multiple HPV transgenic mouse models [34,35]. This evidence concerns the gene MTOR and cancer.